Corduroy Diagnostics, LLC

If you had a chance to save a life would you? CorduroyDx is seeking funds to commercialize a screening & diagnosis test for the early detection of liver cancer

  • Stage Product In Development
  • Industry Biotechnology
  • Location Rockville, MD, USA
  • Currency USD
  • Founded December 2013
  • Employees 0
  • Website corduroydx.com

Company Summary

Use funds to develop and validate blood, saliva, and urine based panel of molecular biomarkers to proof-of-concept for the screening, diagnosis, and staging of liver cancer while providing best-in-class sensitivity, specificity, and positive predictive value. We seek to generate revenues from sublicensing fees, milestone payments, & royalties to become an attractive acquisition target in a hot, growing Hep C/HCC market & generate a great return.

Team

  • Kashif Haque
    CEO

    Current Technology Transfer Licensing Specialist at Roswell Park. Previously, Sales Manager at Cytoo, Inc., Technology Transfer Fellow at NCI TTC, 2011 graduate of the Innovate Program at JHU Business School in Rockville, MD. Chosen due to clinical and business knowledge and overall vision for business.

  • Saravana Murthy
    CSO

    Previously, Research Fellow at NICHD and a 2012 graduate of the Innovate program at JHU Business School in Rockville, MD. Chosen due to technical expertise and prior molecular diagnostic work at NIH.

Advisors

  • None.
    Accountant
    Unconfirmed

Previous Investors

  • None
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free